Civitas Therapeutics to Present at JMP Securities Healthcare Conference

Published: Jul 02, 2013

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Civitas Therapeutics, Inc., a biopharmaceutical company with a lead program in Parkinson’s disease that leverages the ARCUS(TM) respiratory delivery platform, today announced that Glenn Batchelder, President and Chief Executive Officer, will present a corporate update at the JMP Securities Healthcare Conference in New York City on Tuesday, July 9, 2013 at 4:30 p.m. (EDT).

Help employers find you! Check out all the jobs and post your resume.

Back to news